These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2005449)

  • 1. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease.
    Nordyke RA; Gilbert FI
    J Nucl Med; 1991 Mar; 32(3):411-6. PubMed ID: 2005449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
    Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
    J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified method for treating Graves' disease with radioactive 131I.
    Masri MT; Menne M; Rooney BL; Caplan RH
    Wis Med J; 1995 Jan; 94(1):21-5. PubMed ID: 7871797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hyperthyroidism with radioiodine: effects of administered dose on complications and thyroid function].
    Pineda P; Michelsen H; Rivera M; Lillo R; Massardo T; Araya V; Sierralta P; Oviedo S; Liberman C
    Rev Med Chil; 2000 May; 128(5):499-507. PubMed ID: 11008353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioactive iodine in the treatment of Graves' disease.
    Al-Kaabi JM; Hussein SS; Bukheit CS; Woodhouse NJ; Elshafie OT; Bererhi H
    Saudi Med J; 2002 Sep; 23(9):1049-53. PubMed ID: 12370710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of treatment of Graves-Basedow disease with 131I at low calculated doses].
    Gómez Arnaiz N; Gómez Saez JM; Orti Llavería A; Gavaldá Mestre L; Mairal Pairó L; Soler Ramón J
    Rev Clin Esp; 1998 Feb; 198(2):57-60. PubMed ID: 9558917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodine prophylaxis intensification. Influence on radioiodine uptake and activity of 131I used in the treatment of hyperthyroid patients with Graves' disease.
    Baczyk M; Junik R; Ziemnicka K; Sowiński J
    Nuklearmedizin; 2005; 44(5):197-9. PubMed ID: 16395495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
    Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioiodine therapy of autonomously functioning thyroid nodules and Graves' disease].
    Guhlmann CA; Rendl J; Börner W
    Nuklearmedizin; 1995 Feb; 34(1):20-3. PubMed ID: 7724360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine treatment in autoimmune hyperthyroidism: analysis of outcomes in relation to dosage.
    Hernández-Jiménez S; Pachón-Burgos A; Aguilar-Salinas CA; Andrade V; Reynoso R; Ríos A; Reza-Albarrán AA; Mehta R; González-Treviño O; Gómez-Pérez FJ; Pérez-Enríquezi B; Rull JA
    Arch Med Res; 2007 Feb; 38(2):185-9. PubMed ID: 17227727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism?
    Vijayakumar V; Ali S; Nishino T; Nusynowitz M
    Clin Nucl Med; 2006 Nov; 31(11):688-9. PubMed ID: 17053385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow-up and long-term results of radioiodine therapy in immune hyperthyroidism].
    Galvun G
    Acta Med Austriaca; 1987; 14(3-4):99-101. PubMed ID: 3425189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
    Howarth D; Epstein M; Lan L; Tan P; Booker J
    Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.